Price Action Don’t Lie: Is Genesis Healthcare Inc’s Fuel For Real? The Stock Just Increased Again

Price Action Don't Lie: Is Genesis Healthcare Inc's Fuel For Real? The Stock Just Increased Again

The stock of Genesis Healthcare Inc (NYSE:GEN) is a huge mover today! The stock increased 4.32% or $0.15 during the last trading session, hitting $3.62. About 132,042 shares traded hands. Genesis Healthcare Inc (NYSE:GEN) has risen 33.98% since April 22, 2016 and is uptrending. It has outperformed by 28.57% the S&P500.
The move comes after 9 months positive chart setup for the $577.72 million company. It was reported on Nov, 25 by Barchart.com. We have $3.95 PT which if reached, will make NYSE:GEN worth $51.99 million more.

Analysts await Genesis Healthcare Inc (NYSE:GEN) to report earnings on February, 27. They expect $-0.07 earnings per share, down 40.00% or $0.02 from last year’s $-0.05 per share. After $-0.23 actual earnings per share reported by Genesis Healthcare Inc for the previous quarter, Wall Street now forecasts -69.57% EPS growth.

Genesis Healthcare Inc (NYSE:GEN) Ratings Coverage

Out of 4 analysts covering Genesis Healthcare (NYSE:GEN), 0 rate it a “Buy”, 2 “Sell”, while 2 “Hold”. This means 0 are positive. Genesis Healthcare has been the topic of 9 analyst reports since August 10, 2015 according to StockzIntelligence Inc. The stock of Genesis Healthcare Inc (NYSE:GEN) earned “Sector Perform” rating by RBC Capital Markets on Monday, November 21. Bank of America downgraded the shares of GEN in a report on Monday, May 16 to “Underperform” rating. The stock of Genesis Healthcare Inc (NYSE:GEN) earned “Neutral” rating by UBS on Monday, November 9. The firm earned “Outperform” rating on Monday, May 16 by RBC Capital Markets. The firm has “Outperform” rating by RBC Capital Markets given on Tuesday, January 26. Susquehanna maintained Genesis Healthcare Inc (NYSE:GEN) on Tuesday, January 26 with “Neutral” rating. RBC Capital Markets upgraded the shares of GEN in a report on Monday, August 10 to “Sector Perform” rating. The firm has “Sell” rating given on Monday, February 8 by UBS. The stock has “Neutral” rating given by Bank of America on Tuesday, January 26.

According to Zacks Investment Research, “Genesis Healthcare, Inc. provides long-term care, assisted/senior living and rehabilitation therapy. Genesis Healthcare, Inc., formerly known as Skilled Healthcare Group, Inc., is based in Kennett Square, Pennsylvania.”

More notable recent Genesis Healthcare Inc (NYSE:GEN) news were published by: Philly.com which released: “Genesis Healthcare’s biggest landlord sells 92 nursing homes for $1.7B” on November 02, 2016, also Philly.com with their article: “Genesis Healthcare in $52.7M settlement with U.S.” published on August 01, 2016, Prnewswire.com published: “Genesis HealthCare Makes Significant Headway In Capital Strengthening Initiatives” on August 01, 2016. More interesting news about Genesis Healthcare Inc (NYSE:GEN) were released by: Prnewswire.com and their article: “Genesis Healthcare Announces Preliminary 2016 Growth Outlook And Adjusts 2015 …” published on January 25, 2016 as well as Philly.com‘s news article titled: “Genesis HealthCare explains business plan amid losses” with publication date: February 23, 2016.

GEN Company Profile

Genesis Healthcare, Inc., formerly Skilled Healthcare Group, Inc., incorporated on October 21, 2005, is a holding firm that provides post-acute care. The Firm operates through three divisions: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services. It offers inpatient services through its network of over 500 skilled nursing and assisted/senior living facilities in 34 states, consisting of over 475 skilled nursing facilities and over 35 stand-alone assisted/senior living facilities. The Company’s skilled nursing and assisted/senior living facilities have over 61,000 licensed beds, with its states of operation in California, Maryland, Massachusetts, New Jersey, and Pennsylvania. The Company’s services focus primarily on the medical and physical issues facing elderly patients and are provided by its skilled nursing companies, assisted or senior living communities, integrated and third-party rehabilitation therapy business, and other ancillary services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment